Back

Discussant review - LASCAR-AHF

11 May 2024 (14:41 - 14:45)
Organised by: Logo
Congress Presentation Part of: Late breaking clinical trials: medical therapy Pharmacotherapy HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Professor Lars Lund

Karolinska University Hospital, Stockholm (Sweden)

9 More presentations in this session

Presentation thumbnail
A phase 2b, randomised, double-blind, active controlled, multi centre study to evaluate the efficacy, safety and tolerability of oral AZD9977 and dapagliflozin treatment in patients with heart failure
Professor C. Lam (Singapore, SG)
Slides Video
Presentation thumbnail
Discussant review - MIRACLE
Professor M. Packer (Dallas, US)
Slides Video
Presentation thumbnail
A phase 2, randomized, double-blind, placebo-controlled study to assess the tolerability and pharmacodynamic effects of CRD-740, a PDE9 inhibitor, in participants with chronic heart failure
Professor J. Udelson (Boston, US)
Slides Video
Presentation thumbnail
Discussant review - CARDINAL HF
Associate Professor A. Bohm (Bratislava, SK)
Slides Video
Presentation thumbnail
Readily available urinary sodium analysis in patients with acute decompensate Heart Failure
Doctor E. Meekers (Genk, BE)
Slides Video

Access the full session

Session thumbnail
Late breaking clinical trials: medical therapy
Video

The Event

Event poster

Heart Failure 2024

11 May 2024 14:41 CET
You may be interested in
thumbnail
Congress Presentation
Early heart failure ER rule-in
23 May 2023
thumbnail
Congress Presentation
Acute heart failure: emerging medical options.
22 May 2022
thumbnail
Congress Session
Advances in heart failure detection and therapy
10 May 2026
thumbnail
Congress Presentation
Acute HF trial design.
21 May 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources